We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

In this section

Shares

Stockbroker tips from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Broker tips: Fevertree, Schroders, Centrica

Mon 16 February 2026 13:59

(Sharecast News) - Analysts at Berenberg hiked their target price on drinks maker Fevertree from 790p to 920p on Monday as it put the spotlight on its US partnership with Molson Coors.

Another Centrica buyback uncertain ahead of FY results, says Citi

Mon 16 February 2026 13:26

(Sharecast News) - Citi has kept a 'neutral' stance on Centrica ahead of the energy group's annual results this week, raising questions about the company's potential long-term targets.

RBC Capital downgrades Schroders, lifts PT on Nuveen takeover

Mon 16 February 2026 09:42

(Sharecast News) - RBC Capital Markets downgraded Schroders on Monday to 'sector perform' from 'outperform' but lifted the price target to 610p from 440p to reflect the total consideration of its takeover bid from Nuveen.

Berenberg hikes target price on Fevertree

Mon 16 February 2026 09:03

(Sharecast News) - Analysts at Berenberg hiked their target price on drinks maker Fevertree from 790p to 920p on Monday as it put the spotlight on its US partnership with Molson Coors.

Broker tips: AstraZeneca, Morgan Sindall

Fri 13 February 2026 14:11

(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.

Shore Capital lowers AstraZeneca to 'hold'

Fri 13 February 2026 13:59

(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.

Berenberg hikes target price on Morgan Sindall

Fri 13 February 2026 09:26

(Sharecast News) - Analysts at Berenberg hiked their target price on construction firm Morgan Sindall from 5,400p to 5,800p on Friday in order to reflect another strong performance from the group's fit out division.

Broker tips: Unite, Drax, Dunelm, Barratt Redrow, Schroders

Thu 12 February 2026 14:21

(Sharecast News) - JPMorgan reinstated coverage of Unite Group on Thursday at 'overweight' with a 725p price target as it said the stock's recent de-rating was excessive given structural drivers.

JPMorgan reinstates coverage of Unite Group at 'overweight'

Thu 12 February 2026 13:54

(Sharecast News) - JPMorgan reinstated coverage of Unite Group on Thursday at 'overweight' with a 725p price target as it said the de-rating was excessive given structural drivers.

Citi downgrades Drax to 'neutral' from 'buy'

Thu 12 February 2026 13:10

(Sharecast News) - Citi downgraded Drax on Thursday to 'neutral' from 'buy' as it said the shares were already discounting much of the probability-weighted upside, but lifted the price target to 923p from 850p.